search
Back to results

Assessment of a Brief Post Traumatic Stress Disorder Intervention for Use in Botswana

Primary Purpose

Post Traumatic Stress Disorder

Status
Unknown status
Phase
Not Applicable
Locations
Botswana
Study Type
Interventional
Intervention
Brief Relaxation, Education And Trauma HEaling
Sponsored by
University of Botswana
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Post Traumatic Stress Disorder

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Able to understand Setswana or English
  • The patient must meet the Diagnostic and Statistical Manual of Mental Disorders, fifth edition (DSM-5) criteria for any SMI as categorized for this study (schizophrenia, schizophreniform disorder, schizoaffective disorder, bipolar mood disorder, and severe depressive disorder)
  • The patient should meet the criteria for Post-Traumatic Stress Disorder as assessed with the Post Traumatic Checklist-5 (PCL-5)

Exclusion Criteria:

  • Currently engaged in psychotherapy for PTSD
  • On pharmacotherapy management of PTSD (to control for medication effects on PTSD symptoms)
  • Inability to understand informed consent
  • Inability to respond to interview questions
  • Patients who have suicidal ideation and history of a suicide attempt within the past 6 months

Sites / Locations

  • Sbrana Psychiatric HospitalRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

Intervention group

Control group

Arm Description

Participants will receive the BREATHE intervention for three weeks

The participants will receive treatment as usual

Outcomes

Primary Outcome Measures

Post Traumatic Checklist-5
Mean Change from Baseline in the severity of PTSD symptoms as assessed with the PCL-5. Total scores for the Post Traumatic Checklist-5 range between 0 and 80 with a cut off score of 33 or higher suggesting the patient may benefit from PTSD treatment. Patients with scores lower than 33 may indicate the patient has sub-threshold symptoms of PTSD
eSense EDA skin conductance device
Change in physiological arousal as measured with sensors to assess skin conductance
Mini International Neuropsychiatric Interview (MINI) Plus
Assessment of symptoms meeting the criteria for PTSD
Consent rates
to assess the acceptability of the intervention by dividing the number of participants who meet the criteria for PTSD and meet the inclusion criteria for the pilot trial by the number of those who consent to participate in the trial
Adherence rates
to assess acceptability; measured by the total number of sessions attended by the participants and the reasons for non-adherence.
knowledge of PTSD scale (KPTSD)
mean difference in the scores obtained in the knowledge of PTSD scale. Higher scores indicate more knowledge of PTSD.
Acceptability of Intervention measure (AIM)
Calculation of scores in the Acceptability of Intervention measure. Higher scores indicate greater acceptability
Feasibility of Intervention Measure (FIM)
calculation of scores in the Feasibility of Intervention Measure. Higher scores indicate greater feasibility
Patient satisfaction scale
calculation of scores in the satisfaction scale. Higher satisfaction with the intervention will be indicated by high scores on the patient satisfaction scale

Secondary Outcome Measures

Patient Health Questionnaire-9 (PHQ-9)
Mean Change from Baseline in the severity of depressive symptoms as assessed with the PHQ-9
Clinical Outcomes in Routine Evaluation-Outcome Measure
Mean difference from Baseline in the severity of psychological distress
Zung self-rating anxiety scale
Mean Change from Baseline in the severity of anxiety symptoms as assessed with the Zung anxiety rating scale. Total scores in the Zung self rating scale range from 20 to 80, with scores above 26 indicating severe and extremely severe anxiety.
Post Traumatic Checklist-5
Mean Change from Baseline in the severity of PTSD symptoms as assessed with the Post Traumatic Checklist-5. A five points difference in the total score is an indication that a patient has responded to treatment and 10 points has been determined as a minimum threshold for determining whether the improvement has clinical utility

Full Information

First Posted
June 7, 2020
Last Updated
August 29, 2021
Sponsor
University of Botswana
Collaborators
University of KwaZulu
search

1. Study Identification

Unique Protocol Identification Number
NCT04426448
Brief Title
Assessment of a Brief Post Traumatic Stress Disorder Intervention for Use in Botswana
Official Title
The Efficacy, Feasibility, and Acceptability of a Culturally Adapted Brief Intervention for Post-Traumatic Stress Disorder in Severe Mental Illness
Study Type
Interventional

2. Study Status

Record Verification Date
August 2021
Overall Recruitment Status
Unknown status
Study Start Date
July 8, 2020 (Actual)
Primary Completion Date
September 29, 2021 (Anticipated)
Study Completion Date
September 29, 2021 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Botswana
Collaborators
University of KwaZulu

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The purpose of this study is to culturally adapt a brief psychological intervention for Post-Traumatic Stress Disorder (PTSD) and assess its efficacy, feasibility, and acceptability in a pilot trial. The intervention has been shown to be efficacious among individuals with comorbid severe mental illness (SMI) and PTSD. The study will be conducted in three phases. The first phase will determine a description of trauma and responses to traumatic experiences among patients with severe mental illness. The first phase of the study will also determine participants' and mental health care providers' perceptions of suitable PTSD interventions in this middle-income context. The findings will then be used to culturally adapt the brief intervention in the second phase. A pilot trial will be conducted in the third phase of the study. Participants with comorbid SMI and PTSD will be randomized into two groups (n= 20 intervention group, n= 20 control group). Outcomes of the intervention such as the severity of PTSD symptoms, knowledge about PTSD will be assessed at baseline and at different timelines during the study. This study will fill the knowledge gap on trauma and its consequences among individuals with severe mental illness in Botswana, it will also contribute to the improvement of clinical practice in the management of PTSD and SMI.
Detailed Description
Study participants will be recruited from Sbrana Psychiatric Hospital, the only referral psychiatric hospital in Botswana. The hospital population is representative of the culturally diverse Botswana nation because patients with severe mental illness from the entire country are admitted to the hospital. Forty participants (40) will be recruited and randomized to receive the Brief Relaxation, Education, And Trauma HEaling (BREATHE) intervention or treatment as usual. The intervention will be delivered by the Principal Investigator who has received training from the intervention developer. Supervision will be provided telephonically. The BREATHE intervention will be delivered weekly for each participant for a total of three weeks and 4 participants will be enrolled per group resulting in a total of 5 groups. The estimated period of intervention delivery and data collection is therefore expected to last for a period of ~15 weeks. Outcomes such as anxiety, depressive and PTSD Symptoms, and knowledge about PTSD will be assessed before participants receive the intervention, weekly (following each treatment session), month one and month three after treatment completion. Assessment of feasibility and acceptability will be done at treatment completion with the intervention group. Participants on the control arm will receive outcome measures at the same time points as those receiving the intervention. The investigators will utilize an objective assessment of skin conductance which has been shown to be greater in individuals with PTSD than in individuals without PTSD and similarly increased during a trauma interview in individuals with PTSD compared to individuals who do not have PTSD.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Post Traumatic Stress Disorder

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Participants will be randomized into two equal groups.
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
40 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Intervention group
Arm Type
Experimental
Arm Description
Participants will receive the BREATHE intervention for three weeks
Arm Title
Control group
Arm Type
No Intervention
Arm Description
The participants will receive treatment as usual
Intervention Type
Behavioral
Intervention Name(s)
Brief Relaxation, Education And Trauma HEaling
Intervention Description
A three-week psychological intervention for PTSD which comprise psychoeducation and breathing retraining to manage anxiety symptoms
Primary Outcome Measure Information:
Title
Post Traumatic Checklist-5
Description
Mean Change from Baseline in the severity of PTSD symptoms as assessed with the PCL-5. Total scores for the Post Traumatic Checklist-5 range between 0 and 80 with a cut off score of 33 or higher suggesting the patient may benefit from PTSD treatment. Patients with scores lower than 33 may indicate the patient has sub-threshold symptoms of PTSD
Time Frame
baseline, week 1, 2 ,3,
Title
eSense EDA skin conductance device
Description
Change in physiological arousal as measured with sensors to assess skin conductance
Time Frame
baseline, week 1, 2 ,3,
Title
Mini International Neuropsychiatric Interview (MINI) Plus
Description
Assessment of symptoms meeting the criteria for PTSD
Time Frame
baseline, week 3, one month and three months post intervention
Title
Consent rates
Description
to assess the acceptability of the intervention by dividing the number of participants who meet the criteria for PTSD and meet the inclusion criteria for the pilot trial by the number of those who consent to participate in the trial
Time Frame
week 3
Title
Adherence rates
Description
to assess acceptability; measured by the total number of sessions attended by the participants and the reasons for non-adherence.
Time Frame
week 3
Title
knowledge of PTSD scale (KPTSD)
Description
mean difference in the scores obtained in the knowledge of PTSD scale. Higher scores indicate more knowledge of PTSD.
Time Frame
baseline, week 1, 2 ,3, one month and three months post intervention
Title
Acceptability of Intervention measure (AIM)
Description
Calculation of scores in the Acceptability of Intervention measure. Higher scores indicate greater acceptability
Time Frame
week 3
Title
Feasibility of Intervention Measure (FIM)
Description
calculation of scores in the Feasibility of Intervention Measure. Higher scores indicate greater feasibility
Time Frame
week 3
Title
Patient satisfaction scale
Description
calculation of scores in the satisfaction scale. Higher satisfaction with the intervention will be indicated by high scores on the patient satisfaction scale
Time Frame
week 3
Secondary Outcome Measure Information:
Title
Patient Health Questionnaire-9 (PHQ-9)
Description
Mean Change from Baseline in the severity of depressive symptoms as assessed with the PHQ-9
Time Frame
baseline, week 1, 2 ,3, one month and three months post intervention
Title
Clinical Outcomes in Routine Evaluation-Outcome Measure
Description
Mean difference from Baseline in the severity of psychological distress
Time Frame
baseline, week 3, one month and three months post intervention
Title
Zung self-rating anxiety scale
Description
Mean Change from Baseline in the severity of anxiety symptoms as assessed with the Zung anxiety rating scale. Total scores in the Zung self rating scale range from 20 to 80, with scores above 26 indicating severe and extremely severe anxiety.
Time Frame
baseline, week 1, 2 ,3, one month and three months post intervention
Title
Post Traumatic Checklist-5
Description
Mean Change from Baseline in the severity of PTSD symptoms as assessed with the Post Traumatic Checklist-5. A five points difference in the total score is an indication that a patient has responded to treatment and 10 points has been determined as a minimum threshold for determining whether the improvement has clinical utility
Time Frame
one month and three months post intervention

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Able to understand Setswana or English The patient must meet the Diagnostic and Statistical Manual of Mental Disorders, fifth edition (DSM-5) criteria for any SMI as categorized for this study (schizophrenia, schizophreniform disorder, schizoaffective disorder, bipolar mood disorder, and severe depressive disorder) The patient should meet the criteria for Post-Traumatic Stress Disorder as assessed with the Post Traumatic Checklist-5 (PCL-5) Exclusion Criteria: Currently engaged in psychotherapy for PTSD On pharmacotherapy management of PTSD (to control for medication effects on PTSD symptoms) Inability to understand informed consent Inability to respond to interview questions Patients who have suicidal ideation and history of a suicide attempt within the past 6 months
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Keneilwe Molebatsi, MMED (Psychiatry)
Phone
+26777458378
Email
molebatsik@ub.ac..bw
First Name & Middle Initial & Last Name or Official Title & Degree
Julia Gaorekwe
Phone
+2673552900
Email
gaorekwej@ub.ac.bw
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Keneilwe Molebatsi, MMED (Psych)
Organizational Affiliation
University of Botswana
Official's Role
Principal Investigator
Facility Information:
Facility Name
Sbrana Psychiatric Hospital
City
Lobatse
ZIP/Postal Code
0000
Country
Botswana
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Sreekanth Davu, MD Psych
Phone
+26775877248
Email
drsdavu@gmail.com

12. IPD Sharing Statement

Plan to Share IPD
Yes
IPD Sharing Plan Description
The study will be conducted in fulfillment of a Doctor of Philosophy in Psychiatry degree. De-identified data will be shared with the supervisors
IPD Sharing Time Frame
Throughout the study period and one year after completion of write-up
IPD Sharing Access Criteria
de-identified coded data will be stored and shared as a statistical package for the social sciences (SPSS) file.
Citations:
PubMed Identifier
34479640
Citation
Molebatsi K, Ng LC, Chiliza B. A culturally adapted brief intervention for post-traumatic stress disorder in people with severe mental illness in Botswana: protocol for a randomised feasibility trial. Pilot Feasibility Stud. 2021 Sep 3;7(1):170. doi: 10.1186/s40814-021-00904-1.
Results Reference
derived

Learn more about this trial

Assessment of a Brief Post Traumatic Stress Disorder Intervention for Use in Botswana

We'll reach out to this number within 24 hrs